Archford Capital Strategies LLC Buys 511 Shares of IQVIA Holdings Inc. (NYSE:IQV)

Archford Capital Strategies LLC raised its position in IQVIA Holdings Inc. (NYSE:IQV) by 4.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,968 shares of the medical research company’s stock after purchasing an additional 511 shares during the quarter. Archford Capital Strategies LLC’s holdings in IQVIA were worth $2,352,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Private Trust Co. NA boosted its position in IQVIA by 10.7% during the 3rd quarter. Private Trust Co. NA now owns 485 shares of the medical research company’s stock worth $115,000 after acquiring an additional 47 shares during the last quarter. Clear Harbor Asset Management LLC boosted its holdings in IQVIA by 1.3% during the third quarter. Clear Harbor Asset Management LLC now owns 3,969 shares of the medical research company’s stock worth $941,000 after purchasing an additional 50 shares during the last quarter. Pine Valley Investments Ltd Liability Co grew its position in IQVIA by 0.5% in the third quarter. Pine Valley Investments Ltd Liability Co now owns 9,481 shares of the medical research company’s stock valued at $2,247,000 after purchasing an additional 50 shares in the last quarter. Fortitude Family Office LLC increased its stake in IQVIA by 2.9% in the 3rd quarter. Fortitude Family Office LLC now owns 1,977 shares of the medical research company’s stock valued at $468,000 after buying an additional 56 shares during the last quarter. Finally, Huntington National Bank boosted its stake in shares of IQVIA by 7.4% during the 3rd quarter. Huntington National Bank now owns 809 shares of the medical research company’s stock worth $192,000 after buying an additional 56 shares during the last quarter. 89.62% of the stock is owned by institutional investors and hedge funds.

IQVIA Stock Performance

Shares of NYSE:IQV opened at $204.54 on Friday. IQVIA Holdings Inc. has a 12-month low of $187.62 and a 12-month high of $261.73. The company’s 50 day moving average price is $199.71 and its two-hundred day moving average price is $221.06. The firm has a market cap of $37.12 billion, a PE ratio of 26.84, a PEG ratio of 2.14 and a beta of 1.48. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 1.76.

Wall Street Analyst Weigh In

Several research firms recently issued reports on IQV. StockNews.com lowered IQVIA from a “buy” rating to a “hold” rating in a report on Thursday, November 28th. Leerink Partners reaffirmed an “outperform” rating and set a $248.00 price target (down from $260.00) on shares of IQVIA in a research report on Tuesday, November 19th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $270.00 target price on shares of IQVIA in a report on Wednesday, December 11th. Stephens began coverage on IQVIA in a research report on Friday, December 20th. They set an “overweight” rating and a $250.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on IQVIA from $270.00 to $265.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, IQVIA currently has an average rating of “Moderate Buy” and an average target price of $255.71.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.